SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
暂无分享，去创建一个
A. Copas | R. Bruton | A. Hayward | O. Stirrup | L. Shallcross | T. Palmer | P. Moss | M. Krutikov | B. Azmi | N. Kaur | E. Spalkova | P. Sylla | T. Lancaster | Christopher Bentley | A. Jadir | U. Amin | G. Tut | David Bone | Samuel Hulme | R. Giddings | C. Fuller | A. Irwin-Singer | H. Nacer-Laidi | V. Baynton